Abstract
The potential role of protein kinase B (PKB), a serine/threonine protein kinase, in regulating HERG (human ether-a-go-go related gene) K(+) channel function was investigated. Wortmannin (a phosphoinositide 3-kinase (PI3K) inhibitor) caused approximately 30% reduction of HERG current (I(HERG)) stably expressed in HEK293 cells. Transient transfection with the constitutively active PI3K in HERG-expressing HEK293 cells slightly increased ( approximately 7%) I(HERG) while a dominant negative PI3K significantly reduced I(HERG) ( approximately 25%) relative to results in vehicle-transfected cells. I(HERG) was approximately 35% greater in cells transfected with the constitutively activated PKB (caPKB), whereas it was approximately 47% smaller in cells transfected with dominant negative PKB (dnPKB). Basal activation of PKB was detected by immunocytochemistry. PKB activity was significantly enhanced in caPKB-transfected cells and nearly abolished in dnPKB-transfected cells. We conclude that normal HERG function in HEK293 cells requires basal activity of PKB. Our data represent the first evidence that PKB phosphorylation regulates K(+) channels.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Androstadienes / pharmacology
-
CD8 Antigens / metabolism
-
Cation Transport Proteins*
-
Cell Line
-
Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
-
Cyclic AMP-Dependent Protein Kinases / metabolism
-
DNA-Binding Proteins*
-
ERG1 Potassium Channel
-
Enzyme Inhibitors / pharmacology
-
Ether-A-Go-Go Potassium Channels
-
Genes, Dominant
-
Humans
-
Immunohistochemistry / methods
-
Isoquinolines / pharmacology
-
Patch-Clamp Techniques
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors
-
Phosphorylation
-
Potassium Channels / metabolism*
-
Potassium Channels, Voltage-Gated*
-
Protein Serine-Threonine Kinases*
-
Proto-Oncogene Proteins / drug effects
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / metabolism*
-
Proto-Oncogene Proteins c-akt
-
Sulfonamides*
-
Trans-Activators*
-
Transcriptional Regulator ERG
-
Transfection
-
Wortmannin
Substances
-
Androstadienes
-
CD8 Antigens
-
Cation Transport Proteins
-
DNA-Binding Proteins
-
ERG protein, human
-
ERG1 Potassium Channel
-
Enzyme Inhibitors
-
Ether-A-Go-Go Potassium Channels
-
Isoquinolines
-
KCNH2 protein, human
-
KCNH6 protein, human
-
Phosphoinositide-3 Kinase Inhibitors
-
Potassium Channels
-
Potassium Channels, Voltage-Gated
-
Proto-Oncogene Proteins
-
Sulfonamides
-
Trans-Activators
-
Transcriptional Regulator ERG
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins c-akt
-
Cyclic AMP-Dependent Protein Kinases
-
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
-
Wortmannin